Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco Berrino

Showing results (161-170 of 242) with videos related to

Pageof 25
Sort By:
Cell Discovery|July 13, 2017
Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activitiesClaudio Pulito, Federica Mori, Andrea Sacconi, et al.
Cell Discovery|March 14, 2024
Author Correction: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activitiesClaudio Pulito, Federica Mori, Andrea Sacconi, et al.
Cytokine|October 22, 2011
Factors associated with inflammation markers, a cross-sectional analysisTess V Clendenen, Karen L Koenig, Alan A Arslan, et al.
International Journal of Cancer|August 25, 2006
Circulating enterolactone and risk of endometrial cancerAnne Zeleniuch-Jacquotte, Eva Lundin, Andrea Micheli, et al.
International Journal of Cancer|December 4, 2003
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal womenAnnekatrin Lukanova, Eva Lundin, Andrea Micheli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2011
Circulating inflammation markers and risk of epithelial ovarian cancerTess V Clendenen, Eva Lundin, Anne Zeleniuch-Jacquotte, et al.
Cancer Causes & Control : CCC|February 5, 2013
Circulating prolactin levels and risk of epithelial ovarian cancerTess V Clendenen, Alan A Arslan, Anna E Lokshin, et al.
International Journal of Cancer|July 16, 2015
Adherence to WCRF/AICR cancer prevention recommendations and metabolic syndrome in breast cancer patientsEleonora Bruno, Giuliana Gargano, Anna Villarini, et al.
Tumori|April 13, 2012
Lifestyle and breast cancer recurrences: the DIANA-5 trialAnna Villarini, Patrizia Pasanisi, Adele Traina, et al.
Nutrients|September 28, 2021
Adherence to Dietary Recommendations after One Year of Intervention in Breast Cancer Women: The DIANA-5 TrialEleonora Bruno, Vittorio Krogh, Giuliana Gargano, et al.
Pageof 25

Showing results (161-170 of 242) with videos related to

Sort By:
Pageof 25
Cell Discovery|July 13, 2017
Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activitiesClaudio Pulito, Federica Mori, Andrea Sacconi, et al.
Cell Discovery|March 14, 2024
Author Correction: Metformin-induced ablation of microRNA 21-5p releases Sestrin-1 and CAB39L antitumoral activitiesClaudio Pulito, Federica Mori, Andrea Sacconi, et al.
Cytokine|October 22, 2011
Factors associated with inflammation markers, a cross-sectional analysisTess V Clendenen, Karen L Koenig, Alan A Arslan, et al.
International Journal of Cancer|August 25, 2006
Circulating enterolactone and risk of endometrial cancerAnne Zeleniuch-Jacquotte, Eva Lundin, Andrea Micheli, et al.
International Journal of Cancer|December 4, 2003
Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal womenAnnekatrin Lukanova, Eva Lundin, Andrea Micheli, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 7, 2011
Circulating inflammation markers and risk of epithelial ovarian cancerTess V Clendenen, Eva Lundin, Anne Zeleniuch-Jacquotte, et al.
Cancer Causes & Control : CCC|February 5, 2013
Circulating prolactin levels and risk of epithelial ovarian cancerTess V Clendenen, Alan A Arslan, Anna E Lokshin, et al.
International Journal of Cancer|July 16, 2015
Adherence to WCRF/AICR cancer prevention recommendations and metabolic syndrome in breast cancer patientsEleonora Bruno, Giuliana Gargano, Anna Villarini, et al.
Tumori|April 13, 2012
Lifestyle and breast cancer recurrences: the DIANA-5 trialAnna Villarini, Patrizia Pasanisi, Adele Traina, et al.
Nutrients|September 28, 2021
Adherence to Dietary Recommendations after One Year of Intervention in Breast Cancer Women: The DIANA-5 TrialEleonora Bruno, Vittorio Krogh, Giuliana Gargano, et al.
Pageof 25